Main > A2. TRADEMARK. INDEX. R-Rm > Revlimid

Product USA. C

GENERIC NAME This data is not available for free
INDICATION'S - Lymphoma>NHL>FL (EU>OK)
- Lymphoma>NHL>Mantle Cell Lymphoma
- Multiple Myeloma
- Myelo Dysplastic Syndrome
STATUS Approved in EU & USA
USA>Approved. USA Patent Expiration: 07.24.2016
COMPANY This data is not available for free
PATENT NUMBER This data is not available for free

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back